Sequent Scientific Ltd
SEQUENT
Company Profile
Business description
Sequent Scientific Ltd is a pharmaceutical company operating animal health and analytical services. It develops API products and formulations. The company's product portfolio includes products across various therapy classes such as antibiotics, anthelmintics, pain management, and nutrition. The company's geographical segment includes Europe, Asia, and Rest of the world. It generates maximum revenue from Europe.
Contact
Plot No. E7, Road No. 22
301, 3rd Floor, Dosti Pinnacle
Wagle Industrial Estate
Thane (West)
MumbaiMH400 604
INDT: +91 2241114777
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2025
Employees
1,358
Stocks News & Analysis
stocks
Potential moonshot investment at ASX tech leader
Investors may be over optimistic about the prospects for a new revenue source.
stocks
These ASX earnings season dogs may have fallen too far
The longer term outlook for these moated companies looks far brighter than markets seem to be giving them credit for.
stocks
Our view of the supermarkets after earnings
Are the shares of two of Australia’s best known brands attractive?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,478.80 | 74.90 | 0.89% |
| CAC 40 | 8,183.57 | 71.94 | 0.89% |
| DAX 40 | 22,814.88 | 263.45 | 1.17% |
| Dow JONES (US) | 43,840.91 | 601.41 | 1.39% |
| FTSE 100 | 8,863.43 | 53.69 | 0.61% |
| HKSE | 23,006.27 | 64.95 | 0.28% |
| NASDAQ | 18,847.28 | 302.86 | 1.63% |
| Nikkei 225 | 37,785.47 | 629.97 | 1.70% |
| NZX 50 Index | 12,550.05 | 51.37 | -0.41% |
| S&P 500 | 5,954.50 | 92.93 | 1.59% |
| S&P/ASX 200 | 8,245.70 | 73.30 | 0.90% |
| SSE Composite Index | 3,316.93 | 3.97 | -0.12% |